References
- Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–52
- Batzri S, Korn ED. (1973). Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 298:1015–19
- Che QM, Yang L, Chen Y, et al. (2007). Comparison of pharmacokinetics between different doses of baicalein in rats. Chin J New Drugs 16:604–6
- Chen LL, Dou J, Su ZZ, et al. (2011). Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res 91:314–20
- Choi JH, Choi AY, Yoon H, et al. (2010). Baicalein protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis through inhibition of reactive oxygen species production and CHOP induction. Exp Mol Med 42:811–22
- Gandhi NM. (2013). Baicalein protects mice against radiation-induced DNA damages and genotoxicity. Mol Cell Biochem 379:277–81
- Guan P, Lu Y, Qi J, et al. (2011). Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int J Nanomedicine 6:965–74
- He X, Pei L, Tong HH, Zheng Y. (2011). Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability. AAPS PharmSciTech 12:104–13
- Huang HL, Wang YJ, Zhang QY, et al. (2012). Hepatoprotective effects of baicalein against CCl4-induced acute liver injury in mice. World J Gastroenterol 18:6605–13
- Huang YB, Tsai MJ, Wu PC, et al. (2011). Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. J Drug Target 19:709–18
- Isacchi B, Arrigucci S, la Marca G, et al. (2011). Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice. J Liposome Res 21:237–44
- Lai MY, Hsiu SL, Tsai SY, et al. (2003). Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats. J Pharm Pharmacol 55:205–9
- Lee EK, Kim JM, Choi J, et al. (2011). Modulation of NF-kappaB and FOXOs by baicalein attenuates the radiation-induced inflammatory process in mouse kidney. Free Radic Res 45:507–17
- Li Z, Ge L, Qi C, et al. (2005). Role of intestinal first-pass metabolism of baicalein in its absorption process. Pharm Res 22:1050–8
- Liu J, Qiu L, Gao J, Jin Y. (2006). Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Int J Pharm 312:137–43
- Liu WL, Tian R, Hu WJ, et al. (2012). Preparation and evaluation of self-microemulsifying drug delivery system of baicalein. Fitoterapia 83:1532–9
- Maud C, Fabienne N, Nicole C, et al. (2003). Marine lipid-based liposomes increase in vivo FA bioavailability. Lipids 38:551–9
- Park SJ, Choi SG, Davaa E, Park JS. (2011). Encapsulation enhancement and stabilization of insulin in cationic liposomes. Int J Pharm 415:267–72
- Song YK, Hyun SY, Kim HT, et al. (2011). Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes. J Microencapsul 28:151–8
- Stavniichuk R, Drel VR, Shevalye H, et al. (2011). Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation. Exp Neurol 230:106–13
- Szoka Jr F, Papahadjopoulos D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 75:4194–8
- Takahashi H, Chen MC, Pham H, et al. (2011). Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochim Biophys Acta 1813: 1465–74
- Tan ML, Choong PF, Dass CR. (2010). Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides 31:184–93
- Tan QY, Liu S, Chen XL, et al. (2012). Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech 13:535–45
- Vural I, Sarisozen C, Olmez SS. (2011). Chitosan coated furosemide liposomes for improved bioavailability. J Biomed Nanotechnol 7:426–30
- Wang L, Ling Y, Chen Y, et al. (2010). Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett 297:2–8
- Zhang XL, Li ZF, Liu XG. (2001). Review in pharmacological study of Baicalein. Chin Pharmacol Bull 17:711–13